Miller Anestesia

166. Takano H, Manchikalapudi S, Tang XL, et al: Nitric

oxide synthase is the mediator of late preconditio-

ning against myocardial infarction in conscious

rabbits. Circulation 98:441–449, 1998.

167. Xuan YT, Tang XL, Banerjee S, et al: Nuclear factor-

B plays an essential role in the late phase of ische-

mic preconditioning in conscious rabbits. Circ Res

84:1095–1109, 1999.

168. Tonkovic-Capin M, Gross GJ, Bosnjak ZJ, et al:

Delayed cardioprotection by isoflurane: Role of K

ATP

channels.Am J Physiol Heart Circ Physiol 283:H61–

H68, 2002.

169. Masui K, Kashimoto S, Furuya A, et al: Isoflurane

and sevoflurane during reperfusion prevent reco-

very from ischaemia in mitochondrial K

ATP

channel

blocker pretreated hearts. Eur J Anaesthesiol

23:123–129, 2006.

170. Lutz M, Liu H: Inhaled sevoflurane produces

better delayed myocardial protection at 48

versus 24hours after exposure. Anesth Analg

102:984–990, 2006.

171. Mullenheim J, Ebel D, Bauer M, et al: Sevoflurane

confers additional cardioprotection after ischemic

late preconditioning in rabbits. Anesthesiology

99:624–631, 2003.

172. Kehl F, Pagel PS, Krolikowski JG, et al: Isoflurane

does not produce a second window of preconditio-

ning against myocardial infarction in vivo. Anesth

Analg 95:1162–1168, 2002.

173. Chiari PC, Pagel PS, Tanaka K, et al: Intravenous

emulsified halogenated anesthetics produced

acute and delayed preconditioning against myo-

cardial infarction in rabbits. Anesthesiology

101:1160–1166, 2004.

174. Lucchinetti E, Aguirre J, Feng J, et al: Molecular evi-

dence of late preconditioning after sevoflurane

inhalation in healthy volunteers. Anesth Analg

105:629–640, 2007.

175. Tanaka K, Ludwig LM, Krolikowski JG, et al: Iso-

flurane produced delayed preconditioning against

myocardial ischemia and reperfusion injury: role

of cyclooxygenase-2. Anesthesiology 100:525–

531, 2004.

176. Shinmura K, Xuan YT, Tang XL, et al: Inducible

nitric oxide synthase modulates cyclooxygenase-2

activity in the heart of conscious rabbits during the

late phase of ischemic preconditioning. Circ Res

90:602–608, 2002.

177. Bolli R, Manchikalapudi S, Tang XL, et al: The

protective effect of late preconditioning against

myocardial stunning in conscious rabbits is

mediated by nitric oxide synthase: Evidence that

nitric oxide acts both as a trigger and as a media-

tor of the late phase of ischemic preconditioning.

Circ Res 81:1094–1107, 1997.

178. Wang Y, Kodani E, Wang J, et al: Cardioprotec-

tion during the final stage of the late phase of

ischemic preconditioning is mediated by neuro-

nal NOS in concert with cyclooxygenase-2. Circ

Res 95:84–91, 2004.

179. Chiari PC, Bienengraeber MW, Weihrauch D, et al:

Role of endothelial nitric oxide synthase as a trigger

and mediator of isoflurane-induced delayed pre-

conditioning in rabbit myocardium.Anesthesiology

103:74–83, 2005.

180. Wakeno-Takahashi M, Otani H, Nakao S, et al: Iso-

flurane induces second window of preconditioning

through upregulation of inducible nitric oxide syn-

thase in rat heart. Am J Physiol Heart Circ Physiol

289:H2585–H2591, 2005.

181. Wang C, Chiari PC, Weihrauch D, et al: Gender-

specificity of delayed preconditioning by isoflurane

in rabbits: potential role of endothelial nitric oxide

synthase. Anesth Analg 103:274–280, 2006.

182. Shi Y, Hutchins WC, Su J, et al: Delayed cardiopro-

tection with isoflurane: Role of reactive oxygen and

nitrogen.AmJ Physiol Heart Circ Physiol 288:H175–

H184, 2005.

183. Patel HH, Fryer RM, Gross ER, et al: 12-Lipoxy-

genase in opioid-induced delayed cardioprotec-

tion: Gene array, mass spectrometric, and

pharmacological analyses. Circ Res 92:676–682,

2003.

184. Tsutsumi YM, Patel HH, Huang D, et al: Role of

12-lipoxygenase in volatile anesthetic–induced

delayed preconditioning in mice. Am J Physiol

Heart Circ Physiol 291:H979–H983, 2006.

185. Vinten-Johansen J: Involvement of neutrophils in

the pathogenesis of lethal myocardial reperfusion

injury. Cardiovasc Res 61:481–497, 2004.

186. Sato H, Jordan JE, Zhao ZQ, et al: Gradual reperfu-

sion reduces infarct size and endothelial injury but

augments neutrophil accumulation. Ann Thorac

Surg 64:1099–1107, 1997.

187. Vinten-Johansen J,Lefer DJ,Nakanishi K,et al: Con-

trolled coronary hydrodynamics at the time of

reperfusion reduces postischemic injury. Coron

Artery Dis 3:1081–1093, 1992.

188. Kin H, Zhao ZQ, Sun HY, et al: Postconditioning

attenuates myocardial ischemia-reperfusion injury

by inhibiting events in the early minutes of reperfu-

sion. Cardiovasc Res 62:74–85, 2004.

189. Zhao ZQ, Corvera JS, Halkos ME, et al: Inhibition

of myocardial injury by ischemic postconditioning

during reperfusion: Comparison with ischemic pre-

conditioning. Am J Physiol Heart Circ Physiol

285:H579–H588, 2003.

190. Yang XM, Proctor JB, Cui L, et al: Multiple, brief

coronary occlusions during early reperfusion

protect rabbit hearts by targeting cell signaling

pathways. J Am Coll Cardiol 44:1103–1110, 2004.

191. Tsang A, Hausenloy DJ, Mocanu MM, et al: Postcon-

ditioning: A form of “modified reperfusion”protects

myocardium by activating the PI3K-Akt pathway.

Circ Res 95:230–232, 2004.

192. Juhaszova M, Zorov DB, Kim SH, et al: Glycogen

sythase kinase-3b mediates convergence of pro-

tection signaling to inhibit the mitochondrial

permeability transition pore. J Clin Invest

113:1535–1549, 2004.

193. Gateau-Roesch O, Argaud L, Ovize M: Mitochon-

drial permeability transition pore and postconditio-

ning. Cardiovasc Res 70:264–273, 2006.

194. Staat P, Rioufol G, Piot C, et al: Postconditioning

the human heart. Circulation 112:2143–2148,

2005.

195. Hausenloy D,Yellon D: Survival kinases in ischemic

preconditioning and postconditioning. Cardiovasc

Res 70:240–253, 2006.

196. Siegmund B, SchlackW, Ladilov YV, et al: Halothane

protects cardiomyocytes against reoxygenation-in-

duced hypercontracture. Circulation 96:4372–4379,

1997.

197. Schlack W, Preckel B, Barthel H, et al: Halothane

reduces reperfusion injury after regional ischaemia

in the rabbit heart in vivo. Br J Anaesth 79:88–96,

1997.

198. Preckel B, Schlack W, Comfere T, et al: Effects of

enflurane, isoflurane, sevoflurane and desflurane on

reperfusion injury after regional myocardial ischae-

mia in the rabbit heart in vivo. Br J Anaesth 81:905–

912, 1998.

199. Obal D, Preckel B, Scharbatke H, et al: One MAC of

sevoflurane provides protection against reperfusion

injury in the rat heart in vivo. Br J Anaesth 87:905–

911, 2001.

200. Varadarajan SG, An J, Novalija E, et al: Sevoflurane

before or after ischemia improves contractile and

metabolic function while reducing myoplasmic

loading in intact hearts. Anesthesiology

96:125–133, 2002.

201. Heindl B, Reichle FM, Zahler S, et al: Sevoflurane

and isoflurane protect the reperfused guinea pig

heart by reducing postischemic adhesion of

polymorphonuclear neutrophils. Anesthesiology

91:521–530, 1999.

202. Lucchinetti E, da Silva R, Pasch T, et al: Anaes-

thetic preconditioning but not postconditioning

prevents early activation of the deleterious

cardiac remodelling programme: Evidence of

opposing genomic responses in cardioprotection

by pre- and postconditioning. Br J Anaesth

95:140–152, 2005.

203. Chiari PC, Bienengraeber MW, Pagel PS, et al: Iso-

flurane protects against myocardial infarction

during early reperfusion by activation of phospha-

tidylinositol-3-kinase signal transduction: Evi-

dence for anesthetic-induced postconditioning in

rabbits. Anesthesiology 102:102–109, 2005.

204. Feng J, Fischer G, Lucchinetti E, et al: Infarct-

remodeled myocardium is receptive to protec-

tion by isoflurane postconditioning. Role of

protein kinase B/Akt signaling. Anesthesiology

104:1004–1014, 2006.

205. Eefting F, Rensing B, Wigman J, et al: Role of apop-

tosis in reperfusion injury. Cardiovasc Res 61:414–

426, 2004.

206. Weihrauch D, Krolikowski JG, Bienengraeber M,

et al: Morphine enhances isoflurane-induced

postconditioning against myocardial infarction:

The role of phosphatidylinositol-3-kinase and

opioid receptors in rabbits.Anesth Analg 101:942–

949, 2005.

207. Zaugg M, Jamali NZ, Lucchinetti E, et al: Norepine-

phrine-induced apoptosis is inhibited in adult rat

ventricular myocytes exposed to volatile anesthe-

tics. Anesthesiology 93:209–218, 2000.

208. Gross ER, Hsu AK, Gross GJ: Opioid-induced car-

dioprotection occurs via glycogen synthase kinase

inhibition during reperfusion in intact rat hearts.

Circ Res 94:960–966, 2004.

209. Darling CE, Jiang R, Maynard M, et al: Postcon-

ditioning via stuttering reperfusion limits myo-

cardial infarct size in rabbit hearts: Role of

ERK1/2. Am J Physiol Heart Circ Physiol

289:H1618–H1626, 2005.

210. Yang XM, Krieg T, Cui L, et al: NECA and bradyki-

nin at reperfusion reduce infarction in rabbit hearts

by signaling through PI3K, ERK, and NO. J Mol Cell

Cardiol 36:411–421, 2004.

211. Krolikowski JG, Weihrauch D, Bienengraeber M, et

al: Role of Erk1/2, p70s6K, and eNOS in isoflurane-

induced cardioprotection during early reperfusion

in vivo. Can J Anesth 53:174–182, 2006.

212. Feng J, Lucchinetti E, Ahuja P, et al: Isoflurane

postconditioning prevents opening of the mito-

chondrial permeability transition pore through

inhibition of glycogen synthase kinase 3

.Anesthe-

siology 103:987–995, 2005.

213. Tessier-Vetzel D, Tissier R, Waintraub X, et al: Iso-

flurane inhaled at the onset of reperfusion potentia-

tes the cardioprotective effect of ischemic

postconditioning through a NO-dependent mecha-

nism. J Cardiovasc Pharmacol 47:487–492, 2006.

214. Argaud L, Gateau-Roesch O, Raisky O, et al:

Postconditioning inhibits mitochondrial permeabi-

lity transition. Circulation 111:194–197, 2005.

215. Krolikowski JG, Bienengraeber M, Weihrauch D, et

al: Inhibition of mitochondrial permeability transi-

tion enhances isoflurane-induced cardioprotection

during early reperfusion: Role of mitochondrial

ATP

channels. Anesth Analg 101:1590–1596, 2005.

216. Korge P, Honda HM, Weiss JN: K

dependent regu-

lation of matrix volume improves mitochondrial

function under conditions mimicking ischemia-re-

perfusion. Am J Physiol Heart Circ Physiol

289:H66–H77, 2005.

217. Obal D, Dettwiler S, Favoccia C, et al: The influence

of mitochondrial K

ATP

-channels in the cardioprotec-

tion of preconditioning and postconditioning by

sevoflurane in the rat in vivo. Anesth Analg

101:1252–1260, 2005.

218. Tong H, Imahashi K, Steenbergen C, et al: Phos-

phorylation of glycogen synthase kinase-3

during

396

Farmacología y anestesia